Carl Schmid presents to NAIC Special Committee on Race & Insurance on how insurance benefit design impacts prescription drug access for racial and ethnic communities and suggestions for overcoming access barriers by reducing utilization management measures, lowering cost-sharing, offering standardized plans, and enforcing ACA non-discrimination policies.
Carl Schmid presents at National Association of Insurance Commissioners, along with other consumer representatives, on discrimination in insurance benefit design with a focus on prescription drugs and adverse tiering.
HIV+Hep’s Carl Schmid, a consumer representative to the National Association of Insurance Commissioners (NAIC), presents to the NAIC PBM subgroup, along with ACSCAN’s Anna Howard, on how PBM’s impact patient access and affordability of prescription drugs.
HIV+Hep’s Carl Schmid’s presentation before the NAIC Regulatory Framework Task Force on the value of copay assistance for Rx, state laws that ensure copay assistance counts, and ways to mitigate any potential conflicts with those state laws with IRS/Health Savings Account issues.
Examines the federal requirement for private insurers to cover PrEP without cost-sharing, state actions to comply, transparency issues, and next steps for enforcing the requirement.